Literature DB >> 22508042

EMT phenotype is induced by increased Src kinase activity via Src-mediated caspase-8 phosphorylation.

Yang Zhao1, XiaoJun Li, XiangFei Sun, YunFeng Zhang, Hong Ren.   

Abstract

Caspase-8 governs multiple cell responses to the microenvironmental cues. However, its integration of "death-life" signalings remains elusive. In our study, the role of caspase-8-Src is well-established as a promoter for migration or metastasis in Casp8(+)Src(+) A549/H226 cells in vivo and in vitro. In particular for nude mice models, mice implanted with Casp8(+)Src(+) A459/H226 cells remarkably increased spontaneous tumor metastatic burden with a significant survival disadvantage. Additionally, we detect that Src-mediated caspase-8 phosphorylation stimulates Src phosphorylation at Tyr-416 via the linkage of Src SH2 domain with phosph-Tyr-380 site of caspase-8. In turn, activated Src can efficiently induce epithelial-mesenchymal transition (EMT) phenotypic features to promote tumor cells metastasis. Surprisingly, RXDLL motif deletion in the DEDa of caspase-8 attenuates tumor cell migration or metastasis via impairing the recruitment of caspase-8 into the cellular periphery where activated Src is subject to caspase-8 phosphorylation. Together, a simple model is that the peripherization of caspase-8 is well-poised to facilitate Src-mediated caspase-8 phosphrylation at Tyr-380, then binding of phospho-Tyr380 of caspase-8 to Src SH2 domain may maintain Src in an active conformation to induce EMT phenotype, a key step toward cancer metastasis.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22508042     DOI: 10.1159/000338489

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  6 in total

1.  Chorein addiction in VPS13A overexpressing rhabdomyosarcoma cells.

Authors:  Sabina Honisch; Willi Yu; Guilai Liu; Ioana Alesutan; Syeda T Towhid; Anna Tsapara; Sabine Schleicher; Rupert Handgretinger; Christos Stournaras; Florian Lang
Journal:  Oncotarget       Date:  2015-04-30

2.  Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion.

Authors:  Nakho Chang; Hye Won Lee; Joung Eun Lim; Da Eun Jeong; Hye Jin Song; Sudong Kim; Do-Hyun Nam; Hyun Hwan Sung; Byong Chang Jeong; Seong Il Seo; Seong Soo Jeon; Hyun Moo Lee; Han-Yong Choi; Hwang Gyun Jeon
Journal:  Oncotarget       Date:  2016-08-09

3.  The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response.

Authors:  Guangyu Wang; Dandan Xu; Zicheng Zhang; Xinhui Li; Jiaqi Shi; Jie Sun; Huan-Zhong Liu; Xiaobo Li; Meng Zhou; Tongsen Zheng
Journal:  NPJ Precis Oncol       Date:  2021-06-22

4.  Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition.

Authors:  Catherine Wilson; Katrina Nicholes; Daisy Bustos; Eva Lin; Qinghua Song; Jean-Philippe Stephan; Donald S Kirkpatrick; Jeff Settleman
Journal:  Oncotarget       Date:  2014-09-15

5.  Application of single-cell RNA sequencing in optimizing a combinatorial therapeutic strategy in metastatic renal cell carcinoma.

Authors:  Kyu-Tae Kim; Hye Won Lee; Hae-Ock Lee; Hye Jin Song; Da Eun Jeong; Sang Shin; Hyunho Kim; Yoojin Shin; Do-Hyun Nam; Byong Chang Jeong; David G Kirsch; Kyeung Min Joo; Woong-Yang Park
Journal:  Genome Biol       Date:  2016-04-29       Impact factor: 13.583

6.  Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.

Authors:  Ji-Young Ahn; Ji-Sun Lee; Hye-Young Min; Ho-Young Lee
Journal:  Oncotarget       Date:  2015-10-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.